India’s government is asking domestic refiners to provide timely and accurate data on a weekly basis of imports of Russian and U.S. crude, as New Delhi plans to show the data to the U.S.

With AI ambitions outpacing data readiness, CIOs must renovate their data strategies to create unified, AI-ready foundations capable of supporting enterprise-wide use cases. Any organization that ...

Function Health, a startup that offers lab testing and body scans for early disease detection, scored nearly $300 million in series B funding, boosting its valuation to $2.5 billion. Redpoint Ventures ...

From electronic health records and blood tests to the stream of data from wearable devices, the amount of health information people generate is accelerating rapidly. Yet, many users struggle to ...

For much of 2025, the Trump administration's wide-ranging tariffs defied forecasts that the import duties would drive up inflation. But that reprieve appears to be over, with economic data this week ...

World of Warcraft Blizzard devs talk about going back to WoW's beloved expansion continent, Northrend, and rebuilding it for The Last Titan: 'We wanna make sure we're doing justice to those memories' ...

Terry Lane is a writer for Investopedia with 25 years of experience in journalism and communications. He covers personal finance, Congress, government regulations, and economics. The Washington Post / ...

July 15 (Reuters) - The U.S. Food and Drug Administration said on Tuesday it will now review all imports of the products it regulates regardless of their quantity or value, after a federal law ...

Haupt is a health and wellness editor at TIME. Function Health CEO Jonathan Swerdlin Many people have low-level risk factors, such as early signs of heart disease, smoldering inside their body. But ...

Importing Switch saves to Nintendo Switch 2 is something you should automatically be able to do when you first set the system up. However, if you skip the transfer or don't have your original Switch ...

New 100-week data from the ongoing Phase 1/2 study of zigakibart, an investigational anti-APRIL monoclonal antibody, reinforce its potential as a disease-modifying treatment for IgA nephropathy (IgAN) ...